SNRIs have approval from the U.S. Food and Drug Administration (FDA) to treat the symptoms of depression, anxiety disorders, chronic nerve pain, and other health conditions. They do this by changing ...

SNRI use in late pregnancy was associated with an increased risk for hypertensive disorders compared with SSRIs (adjusted hazard ratio [aHR], 1.80; 95% CI, 1.37-2.35). Venlafaxine specifically showed ...

Major depressive disorder (MDD) affects approximately 280 million people globally and is one of the leading causes of disability and low quality of life. One in every three people suffering from MDD ...

Switching from an SSRI to an SNRI typically involves gradually tapering off the SSRI under a doctor’s guidance and starting the SNRI at a low dose. Switching from a selective serotonin reuptake ...

Everybody's different — and everyone's depression is different, too. If you and your doctor decide to try antidepressant medications to help treat your depression, you’ll work together to find one ...

Serotonin-norepinephrine reuptake inhibitor (SNRI) medications are antidepressant drugs that doctors may prescribe to treat depression, anxiety, and some forms of chronic pain. SNRIs may improve mood ...

Pfizer has announced positive topline results from a phase 4 efficacy study of the selective serotonin and norepinephrine reuptake inhibitor (SNRI) desvenlafaxine (Pristiq) extended-release tablets ...

Results showed that discontinuation of any SNRI was associated with withdrawal symptoms, with the highest prevalence linked to venlafaxine and desvenlafaxine. Serotonin-noradrenaline reuptake ...

Desvenlafaxine, the major active metabolite of venlafaxine (Effexor XR, also from Wyeth), is a potent and selective SNRI. The increase in the effects of these neurotransmitters in the central nervous ...

Adding serotonin and norepinephrine reuptake inhibitors (SNRIs) to short-acting opioids for nonmalignant pain in nursing home residents doesn’t seem to boost their risk for delirium compared with ...

ROCKVILLE, Md., July 20 -- Mixing common migraine drugs such as Imitrex (sumatriptan) with antidepressants like Prozac (fluoxetine) or Cymbalta (duloxetine) can trigger a life-threatening condition ...